Treatment for Painful Diabetic Neuropathy

Launched by MCMASTER UNIVERSITY · Jun 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment option for painful diabetic neuropathy (pDN), a condition that causes burning and shooting pain in the arms and legs of people with diabetes. The focus is on a type of brain stimulation called controlled pulse parameter TMS (cTMS), which may help relieve pain more effectively than previous methods. Researchers want to see how a 5-day cTMS treatment affects pain levels and nerve function in individuals with pDN.

To participate in this trial, you need to have a diagnosis of painful diabetic neuropathy. However, if you have a history of other chronic pain, use opioids before being diagnosed with pDN, or have certain psychological conditions, you may not be eligible. If you join the study, you can expect to undergo the cTMS treatment and have your pain and nerve function monitored over the course of the trial. This trial is important because it could lead to a new way to help people suffering from this painful condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A diagnosis of painful diabetic neuropathy (pDN)
• Exclusion Criteria:
• • a known history of moderate to severe chronic pain other than pDN
• • daily use of opioids prior to the pDN diagnosis
• • contraindications to TMS
• • known psychological diagnosis affecting comprehension and inability to participate in the study